BARABE TIMOTHY C 4
4 · Cartesian Therapeutics, Inc. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
BARABE TIMOTHY C
Director
Transactions
- Purchase
Common Stock
2024-08-12$12.70/sh+7,500$95,250→ 21,766 total
Holdings
- 7,600
Stock Option (Right to Buy)
Exercise: $19.66Exp: 2034-01-01→ Common Stock (7,600 underlying)
Footnotes (2)
- [F1]On April 4, 2024, the issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
- [F2]This award will vest in 36 equal monthly installments, so that it shall be fully vested on the third anniversary of the date of grant.